Enzon Pharmaceuticals, Inc. (BST:EZ1)
Germany flag Germany · Delayed Price · Currency is EUR
0.0585
-0.0005 (-0.85%)
At close: Jul 22, 2025

Enzon Pharmaceuticals Company Description

Enzon Pharmaceuticals, Inc. does not have significant operations.

Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002.

Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

Enzon Pharmaceuticals, Inc.
CountryUnited States
Founded1981
IndustryBiological Products, Except Diagnostic Substances
Employees1
CEORichard Feinstein

Contact Details

Address:
20 Commerce Drive
Cranford, Delaware 07016
United States
Phone732 980 4500
Websiteenzon.com

Stock Details

Ticker SymbolEZ1
ExchangeStuttgart Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code2836

Key Executives

NamePosition
Richard FeinsteinChief Executive Officer
Richard FeinsteinChief Financial Officer